FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Aarti Drugs Buyback 2023 and CL Educate Buyback 2023.
Aarti Drugs Buyback 2023 is a Tender Offer buyback proposed to list at BSE, NSE while CL Educate Buyback 2023 is a Open Market Through Stock Exchange proposed to list at BSE, NSE.
Aarti Drugs Limited | CL Educate Limited | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Logo | |||||||||||
Type of Buyback | Tender Offer | Open Market Through Stock Exchange | |||||||||
Listing At | BSE, NSE | BSE, NSE | |||||||||
Face Value | ₹10 per share | ₹5 per share | |||||||||
Buyback Price | ₹900 per share | ₹94 per share | |||||||||
Issue Size | 6,65,000 shares | ||||||||||
Issue Size (Amount) | ₹59.85 Crores | ₹15.00 Crores | |||||||||
Buyback Ratio |
|
||||||||||
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited | |||||||||
Lead Managers | Inga Ventures Pvt Ltd | V B Desai Financial Services Limited | |||||||||
Necessity of the buyback | The Buy Back is being proposed by the Company to fulfill the following objectives:
|
The Buyback is being undertaken for the following reasons (i) The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares; (ii) The Buyback may help in improving return on equity, by reduction in the equity base, thereby leading to an increase in shareholders' value; and (iii) The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares to be accepted under the Buyback offer or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer, without additional investment. |
Aarti Drugs Buyback 2023 and CL Educate Buyback 2023 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aarti Drugs Buyback 2023 Buyback record date is Aug 04, 2023. CL Educate Buyback 2023 Buyback record date is .
Aarti Drugs Limited | CL Educate Limited | |
---|---|---|
Record Date | Aug 04, 2023 | |
Offer Open Date | Aug 09, 2023 | Aug 21, 2023 |
Offer Closure Date | Aug 17, 2023 | Nov 28, 2023 |
Last date for receipt of tender forms | Aug 17, 2023 | |
Finalisation of buyback | Aug 23, 2023 | |
Last Date for settlment of bids | Aug 24, 2023 | |
Last Date for extinguishment of shares | Sep 04, 2023 |
Comparison of Aarti Drugs Buyback 2023 and CL Educate Buyback 2023 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
Aarti Drugs Limited | CL Educate Limited | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
Amount in ₹ Crore |
CL Educate Limited Financial Information (Restated Consolidated)CL Educate Limited's revenue increased by 37.73% and profit after tax (PAT) rose by 63.4% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at BSE | Stock price at BSE (in preceding 3 months)
|
Stock price at BSE (in preceding 3 months)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at NSE | Stock price at NSE (in preceding 3 months)
|
Stock price at NSE (in preceding 3 months)
|
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|